Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at the Credit Suisse Phoenix Healthcare Conference on Wednesday, November 12, 2008, at 10:00 a.m. MST.

Theravance, Inc. (NASDAQ: THRX) reported today its financial results for the quarter ended September 30, 2008. Net loss for the third quarter of 2008 was $20.9 million, compared with $32.4 million for the same period of 2007, a decrease of $11.5 million.

Theravance, Inc.

Theravance, Inc. (NASDAQ: THRX) announced today that the Anti-Infective Drugs Advisory Committee (AIDAC) to the U.S.

Theravance, Inc. (NASDAQ: THRX) today reported that an equity award was made to one new employee. Pursuant to Nasdaq Marketplace Rule 4350(i)(1)(A)(iv), the equity award was granted under the Theravance, Inc.